Advertisement

Cell and Tissue Banking

, Volume 20, Issue 1, pp 11–24 | Cite as

Therapeutic abortion and ectopic pregnancy: alternative sources for fetal stem cell research and therapy in Iran as an Islamic country

  • Parisa Goodarzi
  • Khadijeh Falahzadeh
  • Hamidreza Aghayan
  • Moloud Payab
  • Bagher Larijani
  • Sepideh Alavi-Moghadam
  • Akram Tayanloo-Beik
  • Hossein Adibi
  • Kambiz Gilany
  • Babak ArjmandEmail author
Full Length Review
First Online:

Abstract

Regenerative medicine as a background of stem cell research and therapy has a long history. A wide variety of diseases including Parkinson’s disease, heart diseases, multiple sclerosis, spinal cord injury, diabetes mellitus and etc. are candidate to be treated using different types of stem cells. There are several sources of stem cells such as bone marrow, umbilical cord, peripheral blood, germ cells and the embryo/fetus tissues. Fetal stem cells (FSCs) and embryonic stem cells (ESCs) have been described as the most potent stem cell source. Although their pluri- or multipotent properties leads to promising reports for their clinical applications, owning to some ethical and legal obstacles in different communities such as Muslim countries, care should be taken for therapeutic applications of FSCs and ESCs. Derivation of these cell types needs termination of pregnancy and embryo or fetus life that is prohibited according to almost all rules and teaches in Muslim communities. Abortion and termination of pregnancy under a normal condition for the procurement of stem cell materials is forbidden by nearly all the major world religions such as Islam. Legislated laws in the most of Muslim countries permit termination of pregnancy and abortion only when the life of the mother is severely threatened or when continuing pregnancy may lead to the birth of a mentally retarded, genetically or anatomically malformed child. Based on the rules and conditions in Islamic countries, finding an alternative and biologically normal source for embryonic or fetal stem cell isolation will be too difficult. On the one hand, Muslim scientists have the feasibility for finding of genetically and anatomically normal embryonic or fetal stem cell sources for research or therapy, but on the other hand they should adhere to the law and related regional and local rules in all parts of their investigation. The authors suggest that the utilization of ectopic pregnancy (EP) conceptus, extra-embryonic tissues, and therapeutic abortion materials as a valuable source of stem cells for research and medical purposes can overcome limitations associated with finding the appropriate stem cell source. Pregnancy termination because of the mentioned subjects is accepted by almost all Islamic laws because of maternal lifesaving. Also, there are no ethical or legal obstacles in the use of extra-embryonic or EP derived tissues which lead to candidate FSCs as a valuable source for stem cell researches and therapeutic applications.

Keywords

Ectopic pregnancy Fetal stem cell Islamic ethics Therapeutic abortion 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgements

The authors would like to acknowledge Dr. Mohsen Khorshidi, Dr. Seyed Majid Manavi, Dr. Maryam Kashanian, Mrs. Bararpour, Sara Amidi, Vahideh Ebrahimzadeh, Leila Morad-Abadi, and Rasta Arjmand for their considerable assistance.

References

  1. Abbasi M, Gooshki ES, Allahbedashti N (2014) Abortion in Iranian legal system: a review. Iran J Allergy Asthma Immunol 13(1):71–84PubMedGoogle Scholar
  2. Abdulrazzak H, Moschidou D, Jones G, Guillot PV (2010) Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface 7(Suppl 6):S689–S706PubMedPubMedCentralGoogle Scholar
  3. Aksoy S (2005) Making regulations and drawing up legislation in Islamic countries under conditions of uncertainty, with special reference to embryonic stem cell research. J Med Ethics 31(7):399–403CrossRefPubMedPubMedCentralGoogle Scholar
  4. Allum N, Allansdottir A, Gaskell G, Hampel J, Jackson J, Moldovan A, Priest S, Stares S, Stoneman P (2017) Religion and the public ethics of stem-cell research: attitudes in Europe, Canada and the United States. PLoS ONE 12(4):e0176274CrossRefPubMedPubMedCentralGoogle Scholar
  5. Antonucci I, Pantalone A, Tete S, Salini V, Borlongan CV, Hess D, Stuppia L (2012) Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. Curr Pharm Des 18(13):1846–1863CrossRefPubMedGoogle Scholar
  6. Aramesh K (2007) Abortion: an islamic ethical view. Iran J Allergy Asthma Immunol 6(Suppl. 5):29–33Google Scholar
  7. Asman O (2004) Abortion in Islamic countries—legal and religious aspects. Med Law 23(1):73–89PubMedGoogle Scholar
  8. Bai Q, Desprat R, Klein B, Lemaitre JM, De Vos J (2013) Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective. Curr Gene Ther 13(2):93–98CrossRefPubMedPubMedCentralGoogle Scholar
  9. Baker CL, Pera MF (2018) Capturing totipotent stem cells. Cell Stem Cell 22(1):25–34CrossRefPubMedGoogle Scholar
  10. Baker N, Boyette LB, Tuan RS (2015) Characterization of bone marrow-derived mesenchymal stem cells in aging. Bone 70:37–47CrossRefPubMedGoogle Scholar
  11. Balbi C, Bollini S (2017) Fetal and perinatal stem cells in cardiac regeneration: moving forward to the paracrine era. Placenta 59:96–106CrossRefPubMedGoogle Scholar
  12. Barker RA, Mason SL, Harrower TP, Swain RA, Ho AK, Sahakian BJ, Mathur R, Elneil S, Thornton S, Hurrelbrink C (2013) The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington’s disease. J Neurol Neurosurg Psychiatry 84(6):657–665CrossRefPubMedPubMedCentralGoogle Scholar
  13. Berer M (2017) Abortion law and policy around the world. In search of decriminalization. Health Hum Rights 19(1):13–27PubMedPubMedCentralGoogle Scholar
  14. Bibber B, Sinha G, Lobba AR, Greco SJ, Rameshwar P (2013) A review of stem cell translation and potential confounds by cancer stem cells. Stem Cells Int 2013:241048CrossRefPubMedPubMedCentralGoogle Scholar
  15. Blanpain C, Fuchs E (2006) Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 22:339–373CrossRefPubMedPubMedCentralGoogle Scholar
  16. Blanpain C, Horsley V, Fuchs E (2007) Epithelial stem cells: turning over new leaves. Cell 128(3):445–458CrossRefPubMedPubMedCentralGoogle Scholar
  17. Bradstreet JJ, Sych N, Antonucci N, Klunnik M, Ivankova O, Matyashchuk I, Demchuk M, Siniscalco D (2014) Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study. Cell Transplant 23(1):S105–S112CrossRefPubMedGoogle Scholar
  18. Brody BA (1998) The ethics of biomedical research: an international perspective. Oxford University Press, OxfordGoogle Scholar
  19. Caplan AI (1994) The mesengenic process. Clin Plast Surg 21(3):429–435PubMedGoogle Scholar
  20. Carrese JA, Malek J, Watson K, Lehmann LS, Green MJ, McCullough LB, Geller G, Braddock CH 3rd, Doukas DJ (2015) The essential role of medical ethics education in achieving professionalism: the Romanell Report. Acad Med 90(6):744–752CrossRefPubMedGoogle Scholar
  21. Caulfield T, Kamenova K, Ogbogu U, Zarzeczny A, Baltz J, Benjaminy S, Cassar PA, Clark M, Isasi R, Knoppers B, Knowles L, Korbutt G, Lavery JV, Lomax GP, Master Z, McDonald M, Preto N, Toews M (2015) Research ethics and stem cells: is it time to re-think current approaches to oversight? EMBO Rep 16(1):2–6CrossRefPubMedGoogle Scholar
  22. Cavanagh D, Fleisher A 2nd, Ferguson JH (1964) Inevitable and incomplete abortion. An evaluation of aggressive management. Am J Obstet Gynecol 90:216–221CrossRefPubMedGoogle Scholar
  23. Chamsi-Pasha H, Albar M (2013) Western and Islamic bioethics: how close is the gap? Avicenna J Med 3(1):8–14CrossRefPubMedPubMedCentralGoogle Scholar
  24. Chan J, O’Donoghue K, de la Fuente J, Roberts IA, Kumar S, Morgan JE, Fisk NM (2005) Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23(1):93–102CrossRefPubMedGoogle Scholar
  25. Cohen CB, Brandhorst B, Nagy A, Leader A, Dickens B, Isasi RM, Evans D, Knoppers BM (2008) The use of fresh embryos in stem cell research: ethical and policy issues. Cell Stem Cell 2(5):416–421CrossRefPubMedGoogle Scholar
  26. Condic ML (2013) Totipotency: what it is and what it is not. Stem Cells Dev 23(8):796–812CrossRefPubMedCentralGoogle Scholar
  27. Crisan M, Yap S, Casteilla L, Chen C-W, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3):301–313CrossRefGoogle Scholar
  28. Damas I, Zuliani C, Moraes A, Westin C, Kharmandayan P, Andrade K, Mamonei R, Coimbra I (2018) Comparision between human amniotic fluid and adipous tissue mesenchymal stem cells induced-chondrogenesis cultured in chitosan-xanthan scaffold stimulated with TGF-β3. Osteoarthr Cartil 26:S298–S299CrossRefGoogle Scholar
  29. de Kretser D (2007) Totipotent, pluripotent or unipotent stem cells: a complex regulatory enigma and fascinating biology. J Law Med 15(2):212PubMedGoogle Scholar
  30. de la Fuente J, Fisk N, O’Donoghue K, Chan J, Kumar S, Roberts I (2003) a2b1 and a4b1 integrins mediate the homing of mesenchymal stem/progenitor cells during fetal life. Haematol J 4:13Google Scholar
  31. De Los Angeles A, Ferrari F, Xi R, Fujiwara Y, Benvenisty N, Deng H, Hochedlinger K, Jaenisch R, Lee S, Leitch HG (2015) Hallmarks of pluripotency. Nature 525(7570):469CrossRefPubMedPubMedCentralGoogle Scholar
  32. de Wert G, Mummery C (2003) Human embryonic stem cells: research, ethics and policy. Hum Reprod 18(4):672–682CrossRefPubMedGoogle Scholar
  33. Dolgin E (2013) Time to ditch stand-alone stem cell oversight panels, experts say. Nature Publishing Group, LondonCrossRefGoogle Scholar
  34. Duan L, Yan D, Zeng W, Yang X, Wei Q (2010) Effect of progesterone treatment due to threatened abortion in early pregnancy for obstetric and perinatal outcomes. Early Hum Dev 86(1):41–43CrossRefPubMedGoogle Scholar
  35. Elstner A, Damaschun A, Kurtz A, Stacey G, Arán B, Veiga A, Borstlap J (2009) The changing landscape of European and international regulation on embryonic stem cell research. Stem Cell Res 2(2):101–107CrossRefPubMedGoogle Scholar
  36. Evans MI, Fletcher JC, Zador IE, Newton BW, Quigg MH, Struyk CD (1988) Selective first-trimester termination in octuplet and quadruplet pregnancies: clinical and ethical issues. Obstet Gynecol 71(3 Pt 1):289–296PubMedGoogle Scholar
  37. Fadel HE (2007) Prospects and ethics of stem cell research: an Islamic perspective. J Islam Med Assoc N Am 39(2):73–83Google Scholar
  38. Ferreira MSV, Bienert M, Müller K, Rath B, Goecke T, Opländer C, Braunschweig T, Mela P, Brümmendorf TH, Beier F (2018) Comprehensive characterization of chorionic villi-derived mesenchymal stromal cells from human placenta. Stem Cell Res Ther 9(1):28CrossRefGoogle Scholar
  39. Findlay JK, Gear ML, Illingworth PJ, Junk SM, Kay G, Mackerras AH, Pope A, Rothenfluh HS, Wilton L (2007) Human embryo: a biological definition. Hum Reprod 22(4):905–911CrossRefPubMedGoogle Scholar
  40. Footman K, Keenan K, Reiss K, Reichwein B, Biswas P, Church K (2018) Medical abortion provision by pharmacies and drug sellers in low- and middle-income countries: a systematic review. Stud Fam Plan 49(1):57–70CrossRefGoogle Scholar
  41. Gardner RL (2007) Stem cells and regenerative medicine: principles, prospects and problems. CR Biol 330(6–7):465–473CrossRefGoogle Scholar
  42. Gatrad AR, Sheikh A (2001) Muslim birth customs. Arch Dis Child Fetal Neonatal Ed 84(1):F6–F8CrossRefPubMedPubMedCentralGoogle Scholar
  43. Gheisari Y, Baharvand H, Nayernia K, Vasei M (2012) Stem cell and tissue engineering research in the Islamic republic of Iran. Stem Cell Rev 8(3):629–639CrossRefGoogle Scholar
  44. Gillon R (1994) Medical ethics: four principles plus attention to scope. BMJ Br Med J 309(6948):184–188CrossRefGoogle Scholar
  45. Gomez-Lopez N, Hernandez-Santiago S, Lobb AP, Olson DM, Vadillo-Ortega F (2013) Normal and premature rupture of fetal membranes at term delivery differ in regional chemotactic activity and related chemokine/cytokine production. Reprod Sci 20(3):276–284CrossRefPubMedGoogle Scholar
  46. Götherström C, Ringdén O, Tammik C, Zetterberg E, Westgren M, Le Blanc K (2004) Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190(1):239–245CrossRefPubMedGoogle Scholar
  47. Götherström C, Westgren M, Shaw S, Åström E, Biswas A, Byers PH, Mattar CN, Graham GE, Taslimi J, Ewald U (2014) Pre-and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience. Stem Cells Transl Med 3(2):255–264CrossRefPubMedGoogle Scholar
  48. Griebel CP, Halvorsen J, Golemon TB, Day AA (2005) Management of spontaneous abortion. Am Fam Physician 72(7):1243–1250PubMedGoogle Scholar
  49. Guillot PV, O'Donoghue K, Kurata H, Fisk NM (2006) Fetal stem cells: betwixt and between. Semin Reprod Med 24(5):340–347CrossRefPubMedGoogle Scholar
  50. Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM (2007) Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25(3):646–654CrossRefPubMedGoogle Scholar
  51. Hainline BE, Padilla L-M, Chong SK, Heifetz SA, Palmer C, Zhou FC (1995) Fetal tissue derived from spontaneous pregnancy losses is insufficient for human transplantation. Obstet Gynecol 85(4):619–624CrossRefPubMedGoogle Scholar
  52. Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW, Jaenisch R (2010) Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci 107(20):9222–9227CrossRefPubMedPubMedCentralGoogle Scholar
  53. Hass R, Kasper C, Böhm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9(1):12CrossRefPubMedPubMedCentralGoogle Scholar
  54. Hedayat KM, Shooshtarizadeh P, Raza M (2006) Therapeutic abortion in Islam: contemporary views of Muslim Shiite scholars and effect of recent Iranian legislation. J Med Ethics 32(11):652–657CrossRefPubMedPubMedCentralGoogle Scholar
  55. Hessini L (2007) Abortion and Islam: policies and practice in the Middle East and North Africa. Reprod Health Matters 15(29):75–84CrossRefPubMedGoogle Scholar
  56. Hima Bindu A, Srilatha B (2011) Potency of various types of stem cells and their transplantation. J Stem Cell Res Ther 1:115Google Scholar
  57. Hosseini-Chavoshi M, Abbasi-Shavazi MJ, Glazebrook D, McDonald P (2012) Social and psychological consequences of abortion in Iran. Int J Gynecol Obstet 118(S2):S172–S177CrossRefGoogle Scholar
  58. Huang S, Xia W, Sheng X, Qiu L, Zhang B, Chen T, Xu S, Li Y (2018) Maternal lead exposure and premature rupture of membranes: a birth cohort study in China. BMJ Open 8(7):2018–021565Google Scholar
  59. Hunt JS, Petroff MG, McIntire RH, Ober C (2005) HLA-G and immune tolerance in pregnancy. FASEB J 19(7):681–693CrossRefPubMedGoogle Scholar
  60. Hyun I (2010) Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. J Law Med Ethics 38(2):277–285CrossRefPubMedGoogle Scholar
  61. Ilic D, Polak JM (2011) Stem cells in regenerative medicine: introduction. Br Med Bull 98(1):117–126CrossRefPubMedGoogle Scholar
  62. Iranmanesh M, Moghavvemi S, Zailani S, Hyun SS (2018) The role of trust and religious commitment in Islamic medical tourism. Asia Pac J Tour Res 23(3):245–259CrossRefGoogle Scholar
  63. Ishii T, Eto K (2014) Fetal stem cell transplantation: past, present, and future. World J Stem Cells 6(4):404–420CrossRefPubMedPubMedCentralGoogle Scholar
  64. Jones PBC (2000) Funding of human stem cell research by the United States. Electron J Biotechnol 3(1):15–20CrossRefGoogle Scholar
  65. Juengst E, Fossel M (2001) Ethical issues in embryonic stem cell research—reply. JAMA 285(11):1439–1440CrossRefGoogle Scholar
  66. Kalra K, Tomar P (2014) Stem cell: basics, classification and applications. Am J Phytomed Clin Ther 2(7):919–930Google Scholar
  67. Karamouzian M, Sharifi H, Haghdoost AA (2014) Iran’s shift in family planning policies: concerns and challenges. Int J Health Policy Manag 3(5):231–233CrossRefPubMedPubMedCentralGoogle Scholar
  68. Khanlarkhani N, Baazm M, Mohammadzadeh F, Najafi A, Mehdinejadiani S, Sobhani A (2016) Multipotent stem cell and reproduction. J Stem Cells 11(4):219PubMedGoogle Scholar
  69. Khitamy BAB (2013) Divergent views on abortion and the period of ensoulment. Sultan Qaboos Univ Med J 13(1):26–31CrossRefPubMedPubMedCentralGoogle Scholar
  70. Kraemer B, Kraemer E, Guengoer E, Juhasz-Boess I, Solomayer EF, Wallwiener D, Rajab TK (2009) Ovarian ectopic pregnancy: diagnosis, treatment, correlation to Carnegie stage 16 and review based on a clinical case. Fertil Steril 92(1):392CrossRefPubMedGoogle Scholar
  71. Kusuma GD, Abumaree MH, Pertile MD, Kalionis B (2018) Isolation and characterization of mesenchymal stem/stromal cells derived from human third trimester placental chorionic villi and decidua basalis. Springer, Preeclampsia, pp 247–266Google Scholar
  72. Landry DW, Zucker HA (2004) Embryonic death and the creation of human embryonic stem cells. J Clin Investig 114(9):1184–1186CrossRefPubMedGoogle Scholar
  73. Larijani B (2015) A simple and cost-effective method for isolation and expansion of human fetal pancreas derived mesenchymal stem cells. Arch Iran Med 18(11):770PubMedGoogle Scholar
  74. Larijani B, Zahedi F (2008) Contemporary medical ethics: an overview from Iran. Dev World Bioeth 8(3):192–196CrossRefPubMedGoogle Scholar
  75. Larijani B, Ghahari A, Warnock GL, Aghayan HR, Goodarzi P, Falahzadeh K, Arjmand B (2015) Human fetal skin fibroblasts: extremely potent and allogenic candidates for treatment of diabetic wounds. Med Hypotheses 84(6):577–579CrossRefPubMedGoogle Scholar
  76. Lawrence DJ (2007) The four principles of biomedical ethics: a foundation for current bioethical debate. J Chiropr Humanit 14:34–40CrossRefGoogle Scholar
  77. Lawson AD (2011) What is medical ethics? Trends Anaesth Crit Care 1(1):3–6CrossRefGoogle Scholar
  78. Lee TT-Y, Tsai C-F, Hsieh T-H, Chen J-JJ, Wang Y-C, Kao M-C, Wu R-M, Singh S, Tsai E-M, Lee J-N (2012) Ectopic pregnancy-derived human trophoblastic stem cells regenerate dopaminergic nigrostriatal pathway to treat parkinsonian rats. PLoS ONE 7(12):e52491CrossRefPubMedPubMedCentralGoogle Scholar
  79. Leist M, Bremer S, Brundin P, Hescheler J, Kirkeby A, Krause KH, Poerzgen P, Puceat M, Schmidt M, Schrattenholz A, Zak NB, Hentze H (2008) The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. Altex 25(3):163–190CrossRefPubMedGoogle Scholar
  80. Lo B, Parham L (2009) Ethical issues in stem cell research. Endocr Rev 30(3):204–213CrossRefPubMedPubMedCentralGoogle Scholar
  81. Lo B, Zettler P, Cedars MI, Gates E, Kriegstein AR, Oberman M, Reijo Pera R, Wagner RM, Wuerth MT, Wolf LE (2005) A new era in the ethics of human embryonic stem cell research. Stem Cells 23(10):1454–1459CrossRefPubMedGoogle Scholar
  82. Loewy EH (1989) Textbook of medical ethics. Springer, New YorkCrossRefGoogle Scholar
  83. Long C, Lankford L, Kumar P, Grahn R, Borjesson DL, Farmer D, Wang A (2018) Isolation and characterization of canine placenta-derived mesenchymal stromal cells for the treatment of neurological disorders in dogs. Cytom A 93(1):82–92CrossRefGoogle Scholar
  84. Ma Y, Tang C, Chaly T, Greene P, Breeze R, Fahn S, Freed C, Dhawan V, Eidelberg D (2010) Dopamine cell implantation in Parkinson’s disease: long-term clinical and 18F-FDOPA PET outcomes. J Nucl Med 51(1):7CrossRefPubMedGoogle Scholar
  85. Mahla RS (2016) Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol 2016:6940283CrossRefPubMedPubMedCentralGoogle Scholar
  86. Marcus AJ, Woodbury D (2008) Fetal stem cells from extra-embryonic tissues: do not discard. J Cell Mol Med 12(3):730–742CrossRefPubMedPubMedCentralGoogle Scholar
  87. Mastor W (2018) The embryo in comparative law. J Int bioeth d’ethique des Sci 28(4):131–153CrossRefGoogle Scholar
  88. McCuaig R, Wong D, Gardiner FW, Rawlinson W, Dahlstrom JE, Robson S (2018) Periodontal pathogens in the placenta and membranes in term and preterm birth. Placenta 68:40–43CrossRefPubMedGoogle Scholar
  89. McLaren A (2001a) Ethical and social considerations of stem cell research. Nature 414:129CrossRefGoogle Scholar
  90. McLaren A (2001b) Ethical and social considerations of stem cell research. Nature 414(6859):129CrossRefGoogle Scholar
  91. Michejda M (2002) Spontaneous miscarriages as source of fetal stem cells. Natl Cathol Bioeth Q 2(3):401–411CrossRefPubMedGoogle Scholar
  92. Miremadi T, Salekdeh GH, Aghdami N, Gharanfoli M, Vasei M, Kouhkan A, Baharvand H (2013) Stem cell research and therapy in the Islamic republic of Iran: pioneering in the Islamic world. Stem Cells Dev 22(1):51–57CrossRefPubMedGoogle Scholar
  93. Motedayyen H, Zarnani A-H, Tajik N, Ghotloo S, Rezaei A (2018) Immunomodulatory effects of human amniotic epithelial cells on naive CD4+ T cells from women with unexplained recurrent spontaneous abortion. Placenta 18:182–188Google Scholar
  94. Mousa NA, Bedaiwy MA, Casper RF (2006) Biological and reproductive implications of stem cell research and therapeutics: prospects in the Middle East. Middle East Fertil Soc J 11(3):152–168Google Scholar
  95. Mustafa Y (2014) Islam and the four principles of medical ethics. J Med Ethics 40(7):479–483CrossRefPubMedGoogle Scholar
  96. Nakashima A, Ito M, Shima T, Bac ND, Hidaka T, Saito S (2010) Accumulation of IL-17-positive cells in decidua of inevitable abortion cases. Am J Reprod Immunol 64(1):4–11PubMedGoogle Scholar
  97. Nasli-Esfahani E, Ghodsi M, Amini P, Keshtkar AA, Amiri S, Mojahed-Yazdi N, Tootee A, Larijani B (2015a) Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up. J Diabetes Metab Disord 14:33CrossRefPubMedPubMedCentralGoogle Scholar
  98. Nasli-Esfahani E, Ghodsi M, Amini P, Keshtkar AA, Amiri S, Mojahed-Yazdi N, Tootee A, Larijani B (2015b) Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up. J Diabetes Metab Disord 14(33):014–0126Google Scholar
  99. O’Donoghue K, Fisk NM (2004) Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 18(6):853–875CrossRefPubMedGoogle Scholar
  100. Osmanagaoglu MA, Karahan SC, Aran T, Guven S, Turgut E, Mentese A, Bozkaya H (2014) The diagnostic value of beta-human chorionic gonadotropin, progesterone, and ischemia-modified albumin and their combined use in the prediction of first trimester abortions. Int Sch Res Not 1:846531Google Scholar
  101. Page K (2012) The four principles: can they be measured and do they predict ethical decision making? BMC Med Ethics 13:10CrossRefPubMedPubMedCentralGoogle Scholar
  102. Pappa KI, Anagnou NP (2009a) Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 4(3):423–433CrossRefPubMedGoogle Scholar
  103. Pappa KI, Anagnou NP (2009) Novel sources of fetal stem cells: where do they fit on the developmental continuum?Google Scholar
  104. Park CW, Yoon BH, Park JS, Jun JK (2013) A fetal and an intra-amniotic inflammatory response is more severe in preterm labor than in preterm PROM in the context of funisitis: unexpected observation in human gestations. PLoS ONE 8(5):e62521CrossRefPubMedPubMedCentralGoogle Scholar
  105. Parker M (2007) The best possible child. J Med Ethics 33(5):279–283CrossRefPubMedPubMedCentralGoogle Scholar
  106. Patil AB, Dode P, Ahirrao A (2014) Medical ethics in abortion. Indian J Clin Pract 25(6):544–548Google Scholar
  107. Pfeffer N (2009) How work reconfigures an ‘unwanted’ pregnancy into ‘the right tool for the job’ in stem cell research. Sociol Health Illn 31(1):98–111CrossRefPubMedGoogle Scholar
  108. Rahman MS, Spitzhorn L-S, Wruck W, Hagenbeck C, Balan P, Graffmann N, Bohndorf M, Ncube A, Guillot PV, Fehm T (2018) The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time. Stem Cell Res Ther 9(1):113CrossRefPubMedPubMedCentralGoogle Scholar
  109. Ramasamy TS, Velaithan V, Yeow Y, Sarkar FH (2018) Stem cells derived from amniotic fluid: a potential pluripotent-like cell source for cellular therapy? Curr Stem Cell Res Ther 13(4):252–264CrossRefPubMedGoogle Scholar
  110. Report EC (2009) Donating spare embryos for stem cell research. Fertil Steril 91(3):667–670CrossRefGoogle Scholar
  111. Robertson JA (2010) Embryo stem cell research: ten years of controversy. J Law Med Ethics 38(2):191–203CrossRefPubMedGoogle Scholar
  112. Samadirad B, Khamnian Z, Hosseini MB, Dastgiri S (2012) Congenital anomalies and termination of pregnancy in Iran. J Pregnancy 2012:574513CrossRefPubMedPubMedCentralGoogle Scholar
  113. Saniei M (2013) Human embryonic stem cell science and policy: the case of Iran. Soc Sci Med 98:345–350CrossRefPubMedPubMedCentralGoogle Scholar
  114. Schwartz L (2002) Medical ethics: a case based approach. WB Saunders, LondonGoogle Scholar
  115. Sell S (2004) Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51(1):1–28CrossRefPubMedGoogle Scholar
  116. Sengupta P, Bhattacharya N, Bhattacharya S, Stubblefield PG (2016) Ethics pertaining to the use of aborted human tissues for research and therapeutic purposes. Human fetal growth and development. Springer, New York, pp 575–582Google Scholar
  117. Shah I, Ahman E (2010) Unsafe abortion in 2008: global and regional levels and trends. Reprod Health Matters 18(36):90–101CrossRefPubMedGoogle Scholar
  118. Shobeiri SS, Rahmani Z, Hossein Nataj H, Ranjbaran H, Mohammadi M, Abediankenari S (2015) Uterine natural killer cell and human leukocyte antigen-G1 and human leukocyte antigen-G5 expression in vaginal discharge of threatened-abortion women: a case–control study. J Immunol Res 2015:692198CrossRefPubMedPubMedCentralGoogle Scholar
  119. Singh VK, Saini A, Kalsan M, Kumar N, Chandra R (2016) Describing the stem cell potency: the various methods of functional assessment and in silico diagnostics. Front Cell Dev Biol 4:134PubMedPubMedCentralGoogle Scholar
  120. Siniscalco D, Bradstreet JJ, Sych N, Antonucci N (2013) Perspectives on the use of stem cells for autism treatment. Stem Cells Int 2013:262438CrossRefPubMedPubMedCentralGoogle Scholar
  121. Sipp D, Munsie M, Sugarman J (2018) Emerging stem cell ethics. American Association for the Advancement of Science, WashingtonCrossRefGoogle Scholar
  122. Sobhani A, Khanlarkhani N, Baazm M, Mohammadzadeh F, Najafi A, Mehdinejadiani S, Aval FS (2017) Multipotent stem cell and current application. Acta Med Iran 55(1):6–23PubMedGoogle Scholar
  123. Srikanthan A, Reid RL (2008) Religious and cultural influences on contraception. J Obstet Gynaecol Can 30(2):129–137CrossRefPubMedGoogle Scholar
  124. Sugarman J (2008) Human stem cell ethics: beyond the embryo. Cell Stem Cell 2(6):529–533CrossRefPubMedGoogle Scholar
  125. Suzuki S (2012) Clinical significance of preterm singleton pregnancies complicated by placental abruption following preterm premature rupture of membranes compared with those without p-PROM. ISRN Obstet Gynecol 2012:856971PubMedPubMedCentralGoogle Scholar
  126. Sych N, Klunnyk M, Matiyashchuk I, Demchuk M, Ivankova O (2017a) Complex treatment of multiple sclerosis patients by use of fetal stem cells. J Stem Cell Res Ther 7(386):2Google Scholar
  127. Sych N, Klunnyk M, Matiyashchuk I, Demchuk M, Ivankova O (2017b) Complex treatment of the patients with cerebral palsy using fetal stem cells. J Stem Cell Res Ther 7(378):2Google Scholar
  128. Taylor PA, McElmurry RT, Lees CJ, Harrison DE, Blazar BR (2002) Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients. Blood 99(5):1870–1872CrossRefPubMedGoogle Scholar
  129. Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y, Winarno AS, Seliger G (2018) Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med 46(5):465–488CrossRefGoogle Scholar
  130. Tian Z-M, Chen T, Zhong N, Li Z-C, Yin F, Liu S (2009) Clinical study of transplantation of neural stem cells in therapy of inherited cerebellar atrophy. J Peking Univ Health Sci 41(4):456–458Google Scholar
  131. Till JE, McCulloch EA (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14(2):213–222CrossRefPubMedGoogle Scholar
  132. Trounson A, Thakar RG, Lomax G, Gibbons D (2011) Clinical trials for stem cell therapies. BMC Med 9(1):52CrossRefPubMedPubMedCentralGoogle Scholar
  133. Tuganbekova S, Ulyanova O, Taubaldieva Z, Saparbayev S, Popova N, Kozina L (2015) Fetal pancreatic stem-cell transplant in patients with diabetes mellitus. Exp Clin Transplant 3:160–162Google Scholar
  134. Tyagi S, Rathore P (2012) Inevitable and incomplete abortion. In: Goswami D, Bhasin S, Batra S (eds) Obstetric & gynecological emergencies, 1st edn. JAYPEE, New Delhi, pp 23–30CrossRefGoogle Scholar
  135. Ullah I, Subbarao RB, Rho GJ (2015) Human mesenchymal stem cells-current trends and future prospective. Biosci Rep 35(2):e00191CrossRefPubMedPubMedCentralGoogle Scholar
  136. Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, Armstrong L, Djonov V, Lako M, Stojkovic M (2018) Ethical and safety issues of stem cell-based therapy. Int J Med Sci 15(1):36–45CrossRefPubMedPubMedCentralGoogle Scholar
  137. Wehbe-Alamah H (2008) Bridging generic and professional care practices for Muslim patients through use of Leininger’s culture care modes. Contemp Nurse 28(1–2):83–97CrossRefPubMedGoogle Scholar
  138. Weissman IL (2000) Stem cells: units of development, units of regeneration, and units in evolution. Cell 100(1):157–168CrossRefPubMedGoogle Scholar
  139. Witt R, MacKenzie TC, Peranteau WH (2017) Fetal stem cell and gene therapy. Semin Fetal Neonatal Med 22(6):410–414CrossRefPubMedGoogle Scholar
  140. Wu J, Sun T, Ye C, Yao J, Zhu B, He H (2012) Clinical observation of fetal olfactory ensheathing glia transplantation (OEGT) in patients with complete chronic spinal cord injury. Cell Transplant 21(1_suppl):33–37CrossRefGoogle Scholar
  141. Yari K, Kazemi E, Yarani R, Tajehmiri A (2011) Islamic bioethics for fetus abortion in Iran. Am J Sci Res 18:118–121Google Scholar
  142. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, Thomas K, Austin T, Edwards C, Cuzzourt J (2001) Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264(1):51–62CrossRefPubMedGoogle Scholar
  143. Yuan J, Nguyen CK, Liu X, Kanellopoulou C, Muljo SA (2012) Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science 335:1195–1200CrossRefPubMedPubMedCentralGoogle Scholar
  144. Zabihi Bidgoli A, Ardbili FA (2017) Permissibility of multifetal pregnancy reduction from the shiite point of view. Int J Fertil Steril 10(4):380–389PubMedGoogle Scholar
  145. Zacharias DG, Nelson TJ, Mueller PS, Hook CC (2011) The science and ethics of induced pluripotency: what will become of embryonic stem cells? Mayo Clin Proc 86(7):634–640CrossRefPubMedPubMedCentralGoogle Scholar
  146. Zahedi F, Larijani B (2008) National bioethical legislation and guidelines for biomedical research in the Islamic Republic of Iran. Bull World Health Organ 86(8):630–634CrossRefPubMedPubMedCentralGoogle Scholar
  147. Zhang JY, Li LC (2015) Genetic expression and functional characterization of the RUNX2 gene in human adult bone marrow mesenchymal stem cells. Genet Mol Res 14(4):18210–18217CrossRefPubMedGoogle Scholar
  148. Zou G, Zhang J, Li XW, He L, He G, Duan T (2008) Quantitative fluorescent polymerase chain reaction to detect chromosomal anomalies in spontaneous abortion. Int J Gynaecol Obstet 103(3):237–240CrossRefPubMedGoogle Scholar
  149. Zwicky C, Gerber S, Gasparini D, Forestier F, Hohlfeld P, Tissot J, Schneider P (2000) Preparation and analysis of fetal liver extracts. Bone Marrow Transplant 26(6):667–671CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Parisa Goodarzi
    • 1
  • Khadijeh Falahzadeh
    • 3
  • Hamidreza Aghayan
    • 2
  • Moloud Payab
    • 4
  • Bagher Larijani
    • 5
  • Sepideh Alavi-Moghadam
    • 2
  • Akram Tayanloo-Beik
    • 2
  • Hossein Adibi
    • 6
  • Kambiz Gilany
    • 7
  • Babak Arjmand
    • 2
    • 3
    Email author
  1. 1.Brain and Spinal Cord Injury Research Center, Neuroscience InstituteTehran University of Medical SciencesTehranIran
  2. 2.Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences InstituteTehran University of Medical SciencesTehranIran
  3. 3.Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences InstituteTehran University of Medical SciencesTehranIran
  4. 4.Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences InstituteTehran University of Medical SciencesTehranIran
  5. 5.Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences InstituteTehran University of Medical SciencesTehranIran
  6. 6.Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences InstituteTehran University of Medical SciencesTehranIran
  7. 7.Reproductive Biotechnology Research Center, Avicenna Research InstituteACECRTehranIran

Personalised recommendations

Cite article

Buy options